DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Newsome PN, Fox R, King AL. , et al.
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.

Lancet Gastroenterol Hepatol 2018;
3 (01) 25-36

Download Bibliographical Data

Access:
Access: